Objectives: Acquired (non-Wilsonian) hepato-cerebral degeneration is an infrequent neurologic disorder in patients with liver dysfunction and longstanding portal-systemic shunting. The clinical manifestations include dysarthria, ataxia, tremor, and cognitive dysfunction. Typically, patients with acquired hepatocerebral degeneration respond poorly to medical therapy as the underlying end-stage liver disease remains. Information regarding the effect of orthotopic liver transplant on acquired hepatocerebral degeneration, however, is limited and conflicting.

Materials And Methods: We conducted a review of literature via a PubMed search to summarize the effect of orthotopic liver transplant on acquired hepatocerebral degeneration.

Results: We present a 56-year-old man with compensated hepatitis C cirrhosis who developed acquired hepatocerebral degeneration with Parkinsonian symptoms refractory to conventional Parkinson medical therapy. Orthotopic liver transplant led to marked clinical improvement of the acquired hepatocerebral degeneration. However, the patient developed recurrence of acquired hepatocerebral degeneration 6-week postorthotopic liver transplant as he developed graft failure from aggressive progressive hepatitis C recurrence. Our review found a heterogeneous group of case series, suggesting that the experience with orthotopic liver transplant is variable.

Conclusions: Our experience demonstrates that orthotopic liver transplant may lead to resolution of acquired hepatocerebral degeneration; however, acquired hepatocerebral degeneration may return with recurrent liver disease. Future studies with long-term follow-up are needed.

Download full-text PDF

Source

Publication Analysis

Top Keywords

acquired hepatocerebral
36
hepatocerebral degeneration
32
liver transplant
28
orthotopic liver
20
acquired
10
liver
10
hepatocerebral
9
degeneration
9
improvement acquired
8
degeneration parkinsonian
8

Similar Publications

Manganese is an essential trace mineral that has a vital role in maintaining various body functions. Manganese toxicity, referred to as Manganism, causing parkinsonism is a well-known phenomenon that occurs secondary to chronic environmental and occupational exposure to manganese. Patients with underlying chronic liver disease are also susceptible to the toxic accumulation of manganese since it essentially undergoes biliary excretion.

View Article and Find Full Text PDF
Article Synopsis
  • Focal imaging abnormalities in parkinsonism patients indicate a secondary cause, necessitating a unique diagnostic and treatment approach.
  • Various factors such as vascular issues, brain injuries, and toxic exposures can lead to secondary parkinsonism, presenting with symptoms like rigidity and bradykinesia, often without rest tremor.
  • Neuroimaging, especially MRI, is vital for diagnosis, as recognizing imaging abnormalities in context can lead to effective treatment; many secondary forms are reversible, improving our understanding of Parkinson's disease and brain function.
View Article and Find Full Text PDF

Acquired chronic hepatocerebral degeneration (CAHD) is a rare and irreversible neurological disorder that can occur in patients with chronic liver disease. It is characterized by neurological symptoms similar to parkinsonism and the presence of brain damage secondary to manganese deposition. We present the case of a 60-year-old patient with episodes of recurrent hepatic encephalopathy and diagnosis of CAHD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!